Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ovarian Cancer
Interventions: BIOLOGICAL: aldesleukin|BIOLOGICAL: p53 peptide vaccine|PROCEDURE: in vitro-treated peripheral blood stem cell transplantation
Sponsor: National Cancer Institute (NCI)